The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma

Journal of Urology

Volumn 157, Issue 2, 1997, Pages 544-547

  Bangma, Chris H ^a   Kranse, Ries ^a   Blijenberg, Bert G ^a   Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

neoplasm staging; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER STAGING; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA;

EID: 0031022884     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65197-8     Document Type: Article

References (14)

1. Shinohara, K., Wolf, J. S., Jr., Narayan, P. and Carroll, P. R.: Comparison of prostate specific antigen with prostate specific antigen density for 3 clinical applications. J. Urol., 152: 120, 1994.
2. Bluestein, D. L., Bostwick, D. G., Bergstralh, E. J. and Oesterling, J. E.: Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J. Urol., 151: 1315, 1994.
3. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: Use of prostate specific antigen, clinical stage, and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 150: 110, 1993.
4. Stenman, U., Leinonen, J., Alfthan, H., Rannikko, S., Tuhkanen, K. and Alfthan, O.: A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res., 51: 222, 1991.
5. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M.-T., Nilsson, O., Pettersson, K. and Lovgren, T.: Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin. Chem., 37: 1618, 1991.
6. Christensson, A., Bjork, T., Nilsson, O., Dahlen, U., Matikainen, M.-T., Cockett, A. T. K., Abrahamsson, P. and Lilja, H.: Serum prostate specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer. J. Urol., 150: 100, 1993.
7. Lilja, H., Bjork, T., Abrahamsson, P., Stenman, U., Shaw, N., Dowell, B., Oesterling, J., Pettersson, T. K., Piironen, T. and Lovgren, T.: Improved separation between normals, benign prostatic hyperplasia (BPH), and carcinoma of the prostate by measuring free, complexed and total concentrations of prostate specific antigen. J. Urol., part 2, 151: 400A abstract 692, 1994.
8. King, C., Friese, J., Lauren, L., Dowell, B., Shaw, N., Lilja, H., Stenman, U., Piironen, T. and Pettersson, K.: Measurement on IMx of free and total forms of prostate specific antigen for differentiation of patients with benign prostatic hyperplasia and prostate cancer. Clin. Chem., 40: 1007, 1994.
9. Schröder, T. H.: The TNM classification of prostate carcinoma. Prostate, suppl., 4: 129, 1992.
10. Brawn, P. N., Ayala, A. G., von Eschenbach, A. H., Hussey, D. H. and Johnson, D. E.: Histologic grading study of prostate carcinoma: the development of a new system and comparison with other methods. A preliminary study. Cancer, 49: 525, 1982.
11. Blijenberg, B. G., Bangma, C. H., Kranse, R. and Schröder, F. H.: Analytical evaluation of the new DELFIA free and total prostate-specific antigen assays. Read at International European Congress of Clinical Chemistry, Helsinki, Finland, 1995.
12. Bangma, C. H., Kranse, R., Blijenberg, B. G. and Schröder, F. H.: The value of screening tests in the detection of prostate cancer. Part I. Results of a retrospective evaluation of 1726 men. Part II. A simulation of the role of the free/total prostate-specific antigen ratio, age-specific reference ranges, and PSA density. Urology, 46: 773 and 779, 1995.
13. Bogdanowicz, J. F., Bentvelsen, F. M., Oosterom, R. and Schroeder, F. H.: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia. Scand. J. Urol. Nephrol., suppl., 138: 97, 1991.
14. Bjork, T., Bjartell, A., Abrahamsson, P., Hulkko, S., Di Sant'agnese, A. and Lilja, H.: Alpha-1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia. Urology, 43: 427, 1994.